Cargando…
PM482. SALIVARY ALPHA-AMYLASE (sAA) AS A BIOMARKER FOR THE RESPONSE OF THERAPY IN SCHIZOPHRENIA PATIENTS
Autores principales: | Liaury, Kristian, JayalangkaraTanra, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616417/ http://dx.doi.org/10.1093/ijnp/pyw041.482 |
Ejemplares similares
-
PM375. Electroconvulsive shock ameliorated the schizophrenia-like behavior and attenuated the glial activation in the hippocampus of Gunn Rat
por: Abdul Aziz, Erlyn Limoa Ilhamuddin, et al.
Publicado: (2016) -
Morphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal model
por: Liaury, Kristian, et al.
Publicado: (2012) -
PW02-021 - SAA1 is the strongest predictor of AA in TRAPS
por: Obici, L, et al.
Publicado: (2013) -
Salivary alpha-amylase as a stress biomarker in diseased dogs
por: Hong, Hwa-Ran, et al.
Publicado: (2019) -
Salivary Alpha-Amylase as a Biomarker of Stress in Behavioral Medicine
por: Ali, Nida, et al.
Publicado: (2020)